Minerva Neuroscience: Funding, Investors & Team (Sep 2026)
Minerva Neurosciences is a company in the clinical stage of drug development that specializes in creating and selling a range of products aimed at treating diseases of the central nervous system. Our objective is to enhance the quality of life for patients by providing better treatment options and focusing on their specific needs. Drawing on our deep knowledge and experience in this field, we have obtained a selection of proprietary compounds in various stages of development, each offering unique methods of action.
Minerva Neuroscience has raised $80.0M across 1 funding round on record, the most recent an undisclosed round of $80.0M announced in Oct 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Minerva Neuroscience Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Minerva Neuroscience Funding Rounds
Minerva Neuroscience Founders and Leadership Team
Contact details for the Minerva Neuroscience team: 1 of 1 has an email address on file.
Start 14-day free trial →Minerva Neuroscience Funding Compared to Other Biotechnology Startups
Minerva Neuroscience's latest round of $80.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Minerva Neuroscience in Biotechnology and Cambridge
Companies Similar to Minerva Neuroscience
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Minerva Neuroscience Funding FAQs
What does Minerva Neuroscience do?
Minerva Neurosciences is a company in the clinical stage of drug development that specializes in creating and selling a range of products aimed at treating diseases of the central nervous system. Our objective is to enhance the quality of life for patients by providing better treatment options and focusing on their specific needs. Drawing on our deep knowledge and experience in this field, we have obtained a selection of proprietary compounds in various stages of development, each offering unique methods of action.
How much funding has Minerva Neuroscience raised?
Minerva Neuroscience has raised $80.0M across 1 round on record. The most recent is an undisclosed round of $80.0M announced in Oct 2025.
When did Minerva Neuroscience last raise funding?
Minerva Neuroscience's most recent funding round on record is an undisclosed round of $80.0M, announced in Oct 2025.
Who founded Minerva Neuroscience?
FundedIQ lists Geoff Race (Founder) at Minerva Neuroscience.
Where is Minerva Neuroscience headquartered?
Minerva Neuroscience is based in Cambridge, Massachusetts, United States.
How many employees does Minerva Neuroscience have?
Minerva Neuroscience is in the 1-10 employee band.
How does Minerva Neuroscience's funding compare to other Biotechnology startups?
Minerva Neuroscience's latest round of $80.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Minerva Neuroscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Minerva Neuroscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.